Photo from archive.org
Unlicensed cannabis-based medicinal products (UCBPMs) were reclassified from Schedule 1 to Schedule 2 in 2018 in the UK, allowing doctors on the Specialist Register of the General Medical Council to… Click to show full abstract
Unlicensed cannabis-based medicinal products (UCBPMs) were reclassified from Schedule 1 to Schedule 2 in 2018 in the UK, allowing doctors on the Specialist Register of the General Medical Council to legally issue prescriptions for UCBPMs.[1,2][1] However, there has been evidence showing that
Keywords:
platform developed;
based medicinal;
medicinal products;
cannabis based;
unlicensed cannabis;
medcanhub platform
Journal Title: Clinical medicine
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical medicine
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!